India's Sun Pharmaceuticals Ltd. (524715.BY) said Saturday it had launched an offer to buyout minority shareholders of its unit Caraco Pharmaceutical Laboratories Inc. (CPD), in a bid to delist Caraco.

The drug maker said that it had offered to pay $4.75 per share in cash in a notification to the Bombay Stock Exchange.

Caraco declared a loss in the July-to-September period, and has been facing regulatory problems over the last year, hurting Sun Pharmaceutical's U.S. sales.

-By Bijou George, Dow Jones Newswires; +91-22-6145-6111; bijou.george@dowjones.com
Grafico Azioni Caraco (AMEX:CPD)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di Caraco
Grafico Azioni Caraco (AMEX:CPD)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di Caraco